Electrocardiographic changes during low-dose, short-term therapy of cutaneous leishmaniasis with the pentavalent antimonial meglumine

Electrocardiographic changes during low-dose, short-term therapy of cutaneous leishmaniasis with the pentavalent antimonial meglumine

The pentavalent antimonial (Sb5+) meglumine is the drug of choice for the treatment of cutaneous leishmaniasis (CL) in Brazil. Although the cardiotoxicity of high-dose, long-term Sb5+ therapy is well known, the use of low-dose, short-term meglumine has been considered to be safe and relatively free...

Full description

Bibliographic Details
Main Authors: A.L.P. Ribeiro, J.B. Drummond, A.C. Volpini, A.C. Andrade, V.M.A. Passos
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 1999-03-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
cutaneous leishmaniasis
electrocardiography
QT interval
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X1999000300008&lng=en&tlng=en

Similar Items

Similar Items